These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18184663)

  • 1. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
    Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
    Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse.
    Bullens RW; Halstead SK; O'Hanlon GM; Veitch J; Molenaar PC; Willison HJ; Plomp JJ
    Muscle Nerve; 2005 Jun; 31(6):751-60. PubMed ID: 15793847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
    Halstead SK; O'Hanlon GM; Humphreys PD; Morrison DB; Morgan BP; Todd AJ; Plomp JJ; Willison HJ
    Brain; 2004 Sep; 127(Pt 9):2109-23. PubMed ID: 15289269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome.
    Halstead SK; Humphreys PD; Zitman FM; Hamer J; Plomp JJ; Willison HJ
    J Peripher Nerv Syst; 2008 Sep; 13(3):228-35. PubMed ID: 18844789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.
    Halstead SK; Morrison I; O'Hanlon GM; Humphreys PD; Goodfellow JA; Plomp JJ; Willison HJ
    Glia; 2005 Nov; 52(3):177-89. PubMed ID: 15968629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.
    Plomp JJ; Molenaar PC; O'Hanlon GM; Jacobs BC; Veitch J; Daha MR; van Doorn PA; van der Meché FG; Vincent A; Morgan BP; Willison HJ
    Ann Neurol; 1999 Feb; 45(2):189-99. PubMed ID: 9989621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
    Willison HJ; Plomp JJ
    Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.
    Goodfellow JA; Bowes T; Sheikh K; Odaka M; Halstead SK; Humphreys PD; Wagner ER; Yuki N; Furukawa K; Furukawa K; Plomp JJ; Willison HJ
    J Neurosci; 2005 Feb; 25(7):1620-8. PubMed ID: 15716397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse.
    Rupp A; Morrison I; Barrie JA; Halstead SK; Townson KH; Greenshields KN; Willison HJ
    Exp Neurol; 2012 Feb; 233(2):836-48. PubMed ID: 22197826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury.
    O'Hanlon GM; Humphreys PD; Goldman RS; Halstead SK; Bullens RW; Plomp JJ; Ushkaryov Y; Willison HJ
    Brain; 2003 Nov; 126(Pt 11):2497-509. PubMed ID: 12937083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.
    O'Hanlon GM; Plomp JJ; Chakrabarti M; Morrison I; Wagner ER; Goodyear CS; Yin X; Trapp BD; Conner J; Molenaar PC; Stewart S; Rowan EG; Willison HJ
    Brain; 2001 May; 124(Pt 5):893-906. PubMed ID: 11335692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy.
    McGonigal R; Cunningham ME; Yao D; Barrie JA; Sankaranarayanan S; Fewou SN; Furukawa K; Yednock TA; Willison HJ
    Acta Neuropathol Commun; 2016 Mar; 4():23. PubMed ID: 26936605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome.
    Jacobs BC; Bullens RW; O'Hanlon GM; Ang CW; Willison HJ; Plomp JJ
    Muscle Nerve; 2002 Apr; 25(4):549-58. PubMed ID: 11932973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.
    Kuwabara S; Misawa S; Takahashi H; Sawai S; Kanai K; Nakata M; Mori M; Hattori T; Yuki N
    J Neuroimmunol; 2007 Sep; 189(1-2):158-62. PubMed ID: 17673301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.
    Paparounas K; O'Hanlon GM; O'Leary CP; Rowan EG; Willison HJ
    Brain; 1999 May; 122 ( Pt 5)():807-16. PubMed ID: 10355667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.
    Halstead SK; Humphreys PD; Goodfellow JA; Wagner ER; Smith RA; Willison HJ
    Ann Neurol; 2005 Aug; 58(2):203-10. PubMed ID: 16049921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles.
    Liu JX; Willison HJ; Pedrosa-Domellöf F
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3226-32. PubMed ID: 19255160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
    Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
    Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.